These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3997668)

  • 1. The photodeactivation of hedamycin, an antitumor antibiotic of the pluramycin type.
    Fredenhagen A; Séquin U
    J Antibiot (Tokyo); 1985 Feb; 38(2):236-41. PubMed ID: 3997668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage responses triggered by a highly cytotoxic monofunctional DNA alkylator, hedamycin, a pluramycin antitumor antibiotic.
    Tu LC; Melendy T; Beerman TA
    Mol Cancer Ther; 2004 May; 3(5):577-85. PubMed ID: 15141015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the sequential non-covalent and covalent interactions of the antitumour antibiotic hedamycin with double stranded DNA by NMR spectroscopy.
    Pavlopoulos S; Bicknell W; Wickham G; Craik DJ
    J Mol Recognit; 1999; 12(6):346-54. PubMed ID: 10611644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hedamycin intercalates the DNA helix and, through carbohydrate-mediated recognition in the minor groove, directs N7-alkylation of guanine in the major groove in a sequence-specific manner.
    Hansen M; Yun S; Hurley L
    Chem Biol; 1995 Apr; 2(4):229-40. PubMed ID: 9383425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural investigation of the hedamycin:d(ACCGGT)2 complex by NMR and restrained molecular dynamics.
    Owen EA; Burley GA; Carver JA; Wickham G; Keniry MA
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1602-8. PubMed ID: 11820806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of alkali labile linkages in DNA by hedamycin and use of hedamycin as a probe of protein-DNA complexes.
    Bennett GN
    Nucleic Acids Res; 1982 Aug; 10(15):4581-94. PubMed ID: 7133991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the sequence selectivity of the DNA-alkylating pluramycin antitumour antibiotics DC92-B and hedamycin.
    Prakash AS; Moore AG; Murray V; Matias C; McFadyen WD; Wickham G
    Chem Biol Interact; 1995 Mar; 95(1-2):17-28. PubMed ID: 7697748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hedamycin and rubiflavin complexes with deoxyribonucleic acid and other polynucleotides.
    White HL; White JR
    Biochemistry; 1969 Mar; 8(3):1020-42. PubMed ID: 4305483
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure of the altromycin B (N7-guanine)-DNA adduct. A proposed prototypic DNA adduct structure for the pluramycin antitumor antibiotics.
    Sun D; Hansen M; Clement JJ; Hurley LH
    Biochemistry; 1993 Aug; 32(32):8068-74. PubMed ID: 8347608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of the novel anthraquinone antitumor antibiotics, DC92-B and DC92-D.
    Yasuzawa T; Saitoh Y; Sano H
    J Antibiot (Tokyo); 1990 May; 43(5):485-91. PubMed ID: 2358401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new antitumor antibiotic, kidamycin. IV. Pharmacokinetics of acetyl-kidamycin.
    Umezawa I; Komiyama K; Takeshima H; Hata T; Kono M
    J Antibiot (Tokyo); 1973 Nov; 26(11):669-75. PubMed ID: 4792114
    [No Abstract]   [Full Text] [Related]  

  • 12. The interaction of hedamycin and DC92-B in a sequence selective manner with DNA in intact human cells.
    Murray V; Moore AG; Matias C; Wickham G
    Biochim Biophys Acta; 1995 Apr; 1261(2):195-200. PubMed ID: 7711062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new antibiotic, leucinostatin, derived from Penicillium lilacinum.
    Arai T; Mikami Y; Fukushima K; Utsumi T; Yazawa K
    J Antibiot (Tokyo); 1973 Mar; 26(3):157-61. PubMed ID: 4783199
    [No Abstract]   [Full Text] [Related]  

  • 14. The hedamycin locus implicates a novel aromatic PKS priming mechanism.
    Bililign T; Hyun CG; Williams JS; Czisny AM; Thorson JS
    Chem Biol; 2004 Jul; 11(7):959-69. PubMed ID: 15271354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identity of antibiotic P-42-1 elaborated by Actinomyces tumemacerans with kanchanomycin and albofungin.
    Fukushima K; Ishiwata K; Kuroda S; Arai T
    J Antibiot (Tokyo); 1973 Feb; 26(2):65-9. PubMed ID: 4781285
    [No Abstract]   [Full Text] [Related]  

  • 16. Ankinomycin, a potent antitumor antibiotic.
    Sato Y; Watabe H; Nakazawa T; Shomura T; Yamamoto H; Sezaki M; Kondo S
    J Antibiot (Tokyo); 1989 Jan; 42(1):149-52. PubMed ID: 2590276
    [No Abstract]   [Full Text] [Related]  

  • 17. Hedamycin, a new antitumor antibiotic. I. Production, isolation, and characterization.
    Schmitz H; Crook KE; Bush JA
    Antimicrob Agents Chemother (Bethesda); 1966; 6():606-12. PubMed ID: 5985296
    [No Abstract]   [Full Text] [Related]  

  • 18. Binding of hedamycin to deoxyribonucleic acid and chromatin of testis and liver.
    Jernigan HM; Irvin JL; White JR
    Biochemistry; 1978 Oct; 17(20):4232-9. PubMed ID: 708708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characterization of the 1:1 adduct formed between the antitumor antibiotic hedamycin and the oligonucleotide duplex d(CACGTG)2 by 2D NMR spectroscopy.
    Pavlopoulos S; Bicknell W; Craik DJ; Wickham G
    Biochemistry; 1996 Jul; 35(29):9314-24. PubMed ID: 8755709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hedamycin, a new antitumor antibiotic. II. Biological properties.
    Bradner WT; Heinemann B; Gourevitch A
    Antimicrob Agents Chemother (Bethesda); 1966; 6():613-8. PubMed ID: 5985297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.